RESUMEN
Thiazolyl peptides are a class of highly rigid trimacrocyclic compounds consisting of varying but large numbers of thiazole rings. The need for new antibacterial agents to treat infections caused by resistant bacteria prompted a reinvestigation of this class, leading to the previous isolation of thiazolyl peptides, namely, thiazomycin (5) and thiazomycin A (6), congeners of nocathiacins (1-4). Continued chemical screening led to the isolation of six new thiazolyl peptide congeners (8-13), of which three had truncated structures lacking an indole residue. From these, compound 8 showed activity similar to thiazomycin. Two compounds (9 and 10) showed intermediate activities, and the three truncated compounds (11-13) were essentially inactive. The discovery of the truncated compounds revealed the minimal structural requirements for activity and suggested probable biosynthetic pathways for more advanced compounds. The isolation, structure elucidation, antibacterial activity, and proposed biogenesis of thiazomycins are herein described.
Asunto(s)
Actinomycetales/química , Antibacterianos , Péptidos Cíclicos/aislamiento & purificación , Péptidos , Tiazoles/aislamiento & purificación , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Antibacterianos/farmacología , Técnicas Químicas Combinatorias , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Péptidos/química , Péptidos/aislamiento & purificación , Péptidos/farmacología , Péptidos Cíclicos/química , Péptidos Cíclicos/farmacología , Estereoisomerismo , Tiazoles/química , Tiazoles/farmacologíaRESUMEN
Thiazolyl peptides are a class of thiazole-rich macrocyclic potent antibacterial agents. Recently, we described thiazomycin, a new member of thiazolyl peptides, discovered by a thiazolyl peptide specific chemical screening. This method also allowed for the discovery of a new thiazolyl peptide, thiazomycin A, which carries modification in the oxazolidine ring of the amino sugar moiety. Thiazomycin A is a specific inhibitor of protein synthesis (IC(50) 0.7 microg/mL) and a potent Gram-positive antibacterial agent with minimum inhibitory concentration (MIC) ranging 0.002-0.25 microg/mL. The isolation and structure elucidation and biological activities of thiazomycin A are described.
Asunto(s)
Actinomycetales/química , Antibacterianos/farmacología , Péptidos Cíclicos/farmacología , Staphylococcus aureus/efectos de los fármacos , Tiazoles/farmacología , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Concentración 50 Inhibidora , Pruebas de Sensibilidad Microbiana , Oxazoles/química , Oxazoles/farmacología , Péptidos Cíclicos/química , Péptidos Cíclicos/aislamiento & purificación , Staphylococcus aureus/crecimiento & desarrollo , Tiazoles/química , Tiazoles/aislamiento & purificaciónRESUMEN
Thiazolyl peptides are a class of rigid macrocyclic compounds richly populated with thiazole rings. They are highly potent antibiotics but none have been advanced to clinic due to poor aqueous solubility. Recent progress in this field prompted a reinvestigation leading to the isolation of a new thiazolyl peptide, thiazomycin, a congener of nocathiacins. Thiazomycin possesses an oxazolidine ring as part of the amino-sugar moiety in contrast to the dimethyl amino group present in nocathiacin I. The presence of the oxazolidine ring provides additional opportunities for chemical modifications that are not possible with other nocathiacins. Thiazomycin is extremely potent against Gram-positive bacteria both in vitro and in vivo. The titer of thiazomycin in the fermentation broth was very low compared to the nocathiacins I and III. The lower titer together with its sandwiched order of elution presented significant challenges in large scale purification of thiazomycin. This problem was resolved by the development of an innovative preferential protonation based one- and/or two-step chromatographic method, which was used for pilot plant scale purifications of thiazomycin. The isolation and structure elucidation of thiazomycin is herein described.
Asunto(s)
Actinomycetales/química , Antibacterianos/aislamiento & purificación , Péptidos Cíclicos/aislamiento & purificación , Tiazoles/aislamiento & purificación , Actinomycetales/clasificación , Antibacterianos/química , Cromatografía Liquida/métodos , Fermentación , Bacterias Grampositivas/efectos de los fármacos , Péptidos y Proteínas de Señalización Intercelular , Mutación , Péptidos/química , Péptidos/aislamiento & purificación , Péptidos Cíclicos/química , Solubilidad , Tiazoles/químicaAsunto(s)
Inteligencia Artificial , Simulación por Computador , Desarrollo de Medicamentos , Descubrimiento de Drogas , Inteligencia Artificial/normas , Inteligencia Artificial/tendencias , Desarrollo de Medicamentos/métodos , Desarrollo de Medicamentos/normas , Desarrollo de Medicamentos/tendencias , Descubrimiento de Drogas/métodos , Descubrimiento de Drogas/normas , Descubrimiento de Drogas/tendencias , Predicción , Humanos , Historia Natural , Evaluación de Necesidades , Probabilidad , Ciencia Traslacional BiomédicaRESUMEN
This contribution moves in the direction of answering some general questions about the most effective and useful ways of modelling bioprocesses. We investigate the characteristics of models that are good at extrapolating. We trained three fully predictive models with different representational structures (differential equations, differential equations with inheritance of rates and a network of reactions) on Saccharopolyspora erythraea shake flask fermentation data using genetic programming. The models were then tested on unseen data outside the range of the training data and the resulting performances were compared. It was found that constrained models with mathematical forms analogous to internal mass balancing and stoichiometric relations were superior to flexible unconstrained models, even though no a priori knowledge of this fermentation was used.